Taubel J, Hauke W, Rump S, Viereck J, et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J 2020 Nov 11. pii: 5974817. doi: 10.1093.
PMID: 33245749